---
title: "What will the FDA's decision be on Atacicept by Vera Therapeutics in July 2026?"
canonical_url: https://betcrypto.now/events/what-will-the-fdas-decision-be-on-atacicept-by-vera-therapeutics-in-july-2026
status: settled
trading_closes_at: 2026-07-07T18:20:47+00:00
settled_at: 2026-07-07T18:20:47+00:00
total_volume_usd: 2966.31
venues: ["Kalshi"]
categories: ["Markets"]
prices_as_of: 2026-10-09T09:18:42+00:00
publisher: BetCrypto
data_api: https://betcrypto.now/api/v1/events/what-will-the-fdas-decision-be-on-atacicept-by-vera-therapeutics-in-july-2026
---

# What will the FDA's decision be on Atacicept by Vera Therapeutics in July 2026?

Settled · $2,966 traded · listed on Kalshi

## Result

**Yes** won. Settled 2026-07-07.

## About

If the FDA's decision on Atacicept by Vera Therapeutics in July 2026 is a full approval or an accelerated approval, the market resolves to Yes.

This market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued. 

Atacicept is an investigational biological medicine developed by Vera Therapeutics that acts as a "double interceptor," blocking two proteins — called BAFF and APRIL — that instruct the immune system's B cells to overproduce a defective form of the antibody IgA. Think of BAFF and APRIL as two fuel lines feeding an immune fire in the kidney; atacicept is designed to shut off both simultaneously, dampening the abnormal immune response that drives kidney damage in IgA nephropathy (IgAN).

_From Kalshi's listing._

## Open on a venue

- [Kalshi](https://betcrypto.now/go/e/3223?via=md)

---

Probability is the cross-venue consensus (book midpoints, 0–100%). Venue columns are what buying costs there (the ask). Prices move constantly; re-check at the canonical URL or https://betcrypto.now/api/v1/events/what-will-the-fdas-decision-be-on-atacicept-by-vera-therapeutics-in-july-2026.

BetCrypto is an odds-comparison and information service. It accepts no wagers and gives no betting or financial advice; prediction-market availability depends on where you live.